GREENWICH, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium carbonate, today announced that it will release its third quarter 2025 financial results after market close on Thursday 13 November, 2025. Roshan Pujari, Founder and Chief Executive Officer and Uday Devasper, Chief Financial Officer will host a conference call at 5:30pm ET on Thursday 13 November, 2025 to discuss the Company’s results. Par ...

Expands Distribution and Company’s Mission to Deliver Fresh, Sustainable Produce to Health-Conscious ConsumersBELVIDERE, NJ, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced the commencement of shipments of its USDA Organic herbs product line to The Fresh Market. This new retail initiative reinforces Edibl ...

NXP900 Phase 1b program initiated; single agent study underway, aiming to provide preliminary evidence of clinical efficacy in patients with molecularly and histologically defined advanced cancers; initiation of the combination portion of the program expected by year-endNXP900 Phase 1a dose escalation study successfully completed highlighting robust pharmacodynamic responses at clinically relevant doses facilitating once-daily oral dosingNXP900 clinical drug-drug interaction study in healthy volunteers succ ...

VAL-D’OR, Quebec, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR; FSE: 6CA) is pleased to announce the fourth batch of results from the fully funded 100,000-m drilling program (2 drill rigs) for the Contact Sector and more precisely, the North Contact Zone (NCZ), on its 100%-owned Cadillac Project, located in Val-d’Or (Abitibi, Quebec). The NCZ consists of three parallel high-grade gold zones: NCZ1, NCZ2 and NCZ3, spaced approximately 50 m apart. Strateg ...

核心观点 - 公司上调2025财年调整后税息折旧及摊销前利润指引 重申净销售额和年终杠杆率指引 [1] - 第三季度净销售额和调整后税息折旧及摊销前利润创公司61年历史新高 [4][7] - 公司业务在面临市场销量逆风和关税波动时展现出韧性 [4] 第三季度2025年业绩亮点 - 净销售额增长8%至创纪录的4.249亿美元 去年同期为3.933亿美元 [7] - 净利润为2320万美元 摊薄后每股收益0.12美元 去年同期为740万美元 摊薄后每股收益0.04美元 [7] - 调整后摊薄每股收益为0.22美元 去年同期为0.13美元 [7] - 调整后税息折旧及摊销前利润增至创纪录的8800万美元 去年同期为6480万美元 [7] - 经营活动提供的净现金为2620万美元 去年同期为6370万美元 [7] - 自由现金流为910万美元 去年同期为3960万美元 [7] - 公司以平均每股9.72美元的价格回购约32.56万股普通股 总计320万美元 [7] 资产负债表与流动性 - 总债务为7.095亿美元 2024年12月28日为7.186亿美元 [7] - 净债务为6.718亿美元 2024年12月28日为6.74亿美元 [7] - 可用流动性总计2.769亿美元 包括循环信贷额度下2.392亿美元可用借款以及3770万美元现金及等价物 [7] - 净债务与过去十二个月调整后税息折旧及摊销前利润之比改善至季度末的2.5倍 2024年12月28日为2.8倍 [7] 2025年全年指引更新 - 净销售额指引维持在15.35亿至15.75亿美元不变 [6] - 调整后税息折旧及摊销前利润指引从2.65亿至2.75亿美元上调至2.7亿至2.75亿美元 [6] - 年终杠杆率指引维持在2.4倍不变 [6] 管理层评论 - 首席执行官强调团队执行力 在市场逆风中持续服务客户 [4] - 公司产品用于家庭日常维修和维护项目 业务展现出韧性 [4] - 改善的杠杆率和健康的资产负债表为强劲收官奠定基础 [4] - 持续关注推动股东价值的可持续长期增长机会 [4]

Vancouver, BC, Nov. 04, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCQB: NIOMF) (“First American Uranium”, or the “Company”) is pleased to respond to the announcement by the Government of Canada’s announcement of new international investments and partnerships to strengthen critical-minerals supply chains and advance sustainable resource development. The Company views this initiative as a significant step toward reinforcing Canada’s position in the global supply chain and i ...

SCHAUMBURG, Ill., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kinetic Seas Incorporated (OTCQB: KSEZ), a leader in artificial intelligence and the developer of the Skilliks AI platform, today announced the execution of a landmark addendum significantly expanding its strategic partnership with Sagtec Global Limited (Nasdaq: SAGT). The agreement formally establishes Kinetic Seas as the exclusive AI development and technology partner for Sagtec across Malaysia, Indonesia, Singapore, and the Philippines, creating a power ...

Average Percent Area Reduction of 97% in 4 weeks in diabetic wounds100% diabetic wound closure in ≤ 12 weeksPreclinical sustained antibiofilm activity for a minimum of 7 days WINNIPEG, Manitoba, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) today announced new clinical and pre-clinical data demonstrating the performance of its FDA-cleared revyve® Antimicrobial Wound Gel and revyve Wound Gel Spray in both diabetic foot ulcer healing and burn wound infection contr ...

THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- TWFG, Inc. (NASDAQ: TWFG), a leading independent insurance distribution platform, announced today that it has acquired Alabama Insurance Agency, Inc., and its 20 affiliated locations across the state. This strategic acquisition strengthens TWFG’s presence in the Southeastern United States and reinforces its commitment to delivering personalized insurance solutions through a growing network of independent agents. Alabama Insurance Agency, known for its ...

交易概述 - Royalty Pharma以3.1亿美元收购Blackstone Life Sciences持有的AMVUTTRA特许权权益 [1] - 所收购的特许权权益源于Blackstone于2020年与Alnylam达成的融资合作，该合作旨在支持AMVUTTRA的关键性3期HELIOS-B试验 [1] 产品信息 - AMVUTTRA是一种经FDA批准的RNAi疗法，用于治疗ATTR淀粉样变性，这是一种由错误折叠蛋白在神经、心脏和胃肠道积聚引起的进行性、退行性且致命的疾病 [2] - AMVUTTRA于2025年获得FDA批准用于治疗伴有心肌病的TTR淀粉样变性，并于2022年获批用于治疗伴有多发性神经病的遗传性TTR淀粉样变性 [3] - 全球约有30,000名遗传性TTR淀粉样变性伴多发性神经病患者，以及超过300,000名ATTR心肌病患者，其中仅20%目前得到诊断 [3] 市场表现与前景 - AMVUTTRA在2024年销售额达到约10亿美元，同比增长74% [3] - 根据分析师共识，预计AMVUTTRA销售额到2028年将超过60亿美元 [3] - 伴有心肌病的TTR淀粉样变性是一个快速增长的治疗领域，驱动力来自新的治疗选择和不断提高的诊断率 [3] 交易条款细节 - Royalty Pharma收购了Blackstone持有的AMVUTTRA全球净销售额1%的特许权权益，支付3.1亿美元首付款 [4] - 该特许权权益的有效期将持续至2035年3月 [4] - 此次交易涉及AMVUTTRA自2025年10月1日起的销售额，并排除了作为原始交易一部分支付给Blackstone的固定付款 [4] - 在Blackstone的原始交易中，其投资额为7000万美元 [4] 公司背景 - Royalty Pharma成立于1996年，是生物制药特许权最大的收购方，也是生物制药行业创新的主要资助者 [6] - Royalty Pharma目前的投资组合包含超过35种商业化产品的特许权，以及17种在研产品候选物 [6] - Blackstone Life Sciences是行业领先的私募投资平台，目前管理着120亿美元资产 [7]